DRN, ICF and Vetruus

Ethica Corporate Finance advised the D.R.N., I.C.F. and Vetruus’ shareholders in the sale of the Group to the swedish player Nextmune AB

Ethica Corporate Finance assisted the shareholders of DRN, ICF and Vetruus – a Group operating in the formulation, production and distribution of veterinary solutions, complete and complementary pet food and feeds – in the sale to the Swedish company Nextmune AB.

Founded in 1986, the Group today represents one of the main Italian players, active in the world of the pet-care, focused on the formulation of veterinary solutions for various therapeutic areas such as dermatology, otology, stomatology and ophthalmology and production of complementary food, effective for the most common diseases of pets.

The Group has built its growth on a business model mainly aimed at specialized shops and pharmacies channels, with particular attention to the research and development phase for the formulation, with the collaboration of research laboratories and universities, of products that use mainly natural ingredients and that do not foresee the usage of antibiotic